DOW JONES26,295.33-662.26 -2.46%
S&P 5003,038.43-77.96 -2.50%
NASDAQ8,649.56-331.21 -3.69%

Karyopharm Sees Prelim. Q4 XPOVIO Sales $17M-$18M, Prelim. FY19 XPOVIO Sales $30M-$31M

Benzinga · 01/13/2020 12:26